Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2020

01-12-2020 | Methotrexate | Research article

Methodological and reporting quality evaluation of meta-analyses on the Chinese herbal preparation Zheng Qing Feng Tong Ning for the treatment of rheumatoid arthritis

Authors: Mingge Liang, Lan Yan, Zhigang Mei, Yanan Luo, Xiaoqiang Hou, Zhitao Feng

Published in: BMC Complementary Medicine and Therapies | Issue 1/2020

Login to get access

Abstract

Background

Zheng Qing Feng Tong Ning (ZQFTN) is a sinomenine (SIN) preparation that has been used in clinical practice. Our study aimed to assess the methodological and reporting quality of meta-analyses on the Chinese herbal formula ZQFTN for the treatment of rheumatoid arthritis (RA).

Methods

Systematic searches were carried out with the 5 following electronic databases from inception to July 2019: China National Knowledge Infrastructure (CNKI), Wanfang, VIP database for Chinese technical periodicals (VIP), Cochrane Library and PubMed. The quality of the methodology and reporting was measured with the assessment of multiple systematic reviews 2 (AMSTAR 2) scale, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE).

Results

Eight studies were identified. Among the 16 items of the AMSTAR 2 scale, four items were optimally reported (“Y” =100% of the items), and another four items were poorly reported (“Y” =0% of the items). Only 2 studies received a good overall score (“Y” ≥50% of the items). Regarding the PRISMA statement, the scores of 5 studies were lower than the average score (17.69), indicating that the quality of the reports was very low. In terms of the GRADE, none of the 61 results were of high quality (0.0%). Fifteen results were of medium quality (25%), 34 were of low quality (55%), and 12 were of very low quality (20%). Among the five downgrading factors, deviation risk (n = 61, 100%) was the most common downgrading factor, followed by inconsistency (n = 30, 50%), publication bias (n = 17, 28%), inaccuracy (n = 11, 18%) and indirectness (n = 0, 0%).

Conclusions

The methodological and reporting quality of the meta-analyses and systematic reviews in the included studies are less than optimal, and researchers should undergo additional training and follow the AMSTAR 2 scale, PRISMA statement and GRADE to design high-quality studies in the future.
Appendix
Available only for authorised users
Literature
1.
go back to reference Standish KA, Huang CC, Curran ME. Comprehensive analysis of treatment response phenotypes in rheumatoid arthritis for pharmacogenetic studies. Arthritis Res Ther. 2017;19:90–100.PubMedPubMedCentral Standish KA, Huang CC, Curran ME. Comprehensive analysis of treatment response phenotypes in rheumatoid arthritis for pharmacogenetic studies. Arthritis Res Ther. 2017;19:90–100.PubMedPubMedCentral
2.
go back to reference Bader L, Gullaksen SE, Blaser N, Bader L, Brun M, Bringeland GH, Sulen A, Gjesdal CG, Vedeler C, Gavasso S. Candidate Markers for Stratification and Classification in Rheumatoid Arthritis. Front Immunol. 2019;10:1488.PubMedPubMedCentral Bader L, Gullaksen SE, Blaser N, Bader L, Brun M, Bringeland GH, Sulen A, Gjesdal CG, Vedeler C, Gavasso S. Candidate Markers for Stratification and Classification in Rheumatoid Arthritis. Front Immunol. 2019;10:1488.PubMedPubMedCentral
3.
go back to reference Almoallim H, Janoudi N, Alokaily F, Alzahrani Z, Algohary S, Alosaimi H, Attar S. Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry. Open Access Rheumatol. 2019;11:89–95.PubMedPubMedCentral Almoallim H, Janoudi N, Alokaily F, Alzahrani Z, Algohary S, Alosaimi H, Attar S. Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry. Open Access Rheumatol. 2019;11:89–95.PubMedPubMedCentral
4.
go back to reference Zhu LF, Feng YR, Xu DY. Advances in research on quality of life in patients with rheumatoid arthritis. Rheum Arthritis. 2018;7:76–80. Zhu LF, Feng YR, Xu DY. Advances in research on quality of life in patients with rheumatoid arthritis. Rheum Arthritis. 2018;7:76–80.
5.
go back to reference McInnes IB, Kim HY, Lee SH, Mandel D, Song YW, Connell CA, Luo Z, Brosnan MJ, Zuckerman A, Zwillich SH, Bradley JD. Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study. Ann Rheum Dis. 2014;73:124–31.PubMed McInnes IB, Kim HY, Lee SH, Mandel D, Song YW, Connell CA, Luo Z, Brosnan MJ, Zuckerman A, Zwillich SH, Bradley JD. Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study. Ann Rheum Dis. 2014;73:124–31.PubMed
6.
go back to reference Venkatesha SH, Rajaiah R, Berman BM, Moudgil KD. Immunomodulation of Autoimmune Arthritis by Herbal CAM. Evid Based Complement Alternat Med. 2011;2011:986797.PubMed Venkatesha SH, Rajaiah R, Berman BM, Moudgil KD. Immunomodulation of Autoimmune Arthritis by Herbal CAM. Evid Based Complement Alternat Med. 2011;2011:986797.PubMed
7.
go back to reference Boytsov NN, Bhattacharya R, Saverno K, Dixon L, Abbott PL, Zhang X, Gaich CL, Nair R. Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis. J Manag Care Spec Pharm. 2019;25:879–87.PubMed Boytsov NN, Bhattacharya R, Saverno K, Dixon L, Abbott PL, Zhang X, Gaich CL, Nair R. Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis. J Manag Care Spec Pharm. 2019;25:879–87.PubMed
8.
go back to reference Verhoeven MM, de Hair MJ, Tekstra J, Bijlsma JW, van Laar JM, Pethoe-Schramm A, Borm ME, Ter Borg EJ, Linn-Rasker SP, Teitsma XM, Lafeber FP, Jacobs JW, Welsing PM. Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials. Ann Rheum Dis. 2019;2019:215304. Verhoeven MM, de Hair MJ, Tekstra J, Bijlsma JW, van Laar JM, Pethoe-Schramm A, Borm ME, Ter Borg EJ, Linn-Rasker SP, Teitsma XM, Lafeber FP, Jacobs JW, Welsing PM. Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials. Ann Rheum Dis. 2019;2019:215304.
9.
go back to reference Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S. Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol. 2019;234:10018–31.PubMed Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S. Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol. 2019;234:10018–31.PubMed
10.
go back to reference Feng Z, Xu J, He G, Cao M, Duan L, Chen L, Wu Z. The Efficacy and Safety of the Combination of Total Glucosides of Peony and Leflunomide for the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:9852793.PubMedPubMedCentral Feng Z, Xu J, He G, Cao M, Duan L, Chen L, Wu Z. The Efficacy and Safety of the Combination of Total Glucosides of Peony and Leflunomide for the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:9852793.PubMedPubMedCentral
11.
go back to reference Feng ZT, Xu J, He GC, Cai SJ, Li J, Mei ZG. A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis. Clin Rheumatol. 2018;37:35–42.PubMed Feng ZT, Xu J, He GC, Cai SJ, Li J, Mei ZG. A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis. Clin Rheumatol. 2018;37:35–42.PubMed
12.
go back to reference Zhao XX, Peng C, Zhang H, Qin LP. Sinomenium acutum: a review of chemistry, pharmacology, pharmacokinetics, and clinical use. Pharm Biol. 2012;50:1053–61.PubMed Zhao XX, Peng C, Zhang H, Qin LP. Sinomenium acutum: a review of chemistry, pharmacology, pharmacokinetics, and clinical use. Pharm Biol. 2012;50:1053–61.PubMed
13.
go back to reference Shen P, Tu S, Wang H, Qin K, Chen Z. Simiao Pill Attenuates Collagen-Induced Arthritis in Rats through Suppressing the ATX-LPA and MAPK Signalling Pathways. Evid Based Complement Alternat Med. 2019;2019:7498527.PubMedPubMedCentral Shen P, Tu S, Wang H, Qin K, Chen Z. Simiao Pill Attenuates Collagen-Induced Arthritis in Rats through Suppressing the ATX-LPA and MAPK Signalling Pathways. Evid Based Complement Alternat Med. 2019;2019:7498527.PubMedPubMedCentral
14.
go back to reference Zhou YY, Xia X, Peng WK, Wang QH, Peng JH, Li YL, Wu JX, Zhang JY, Zhao Y, Chen XM, Huang RY, Jakobsson PJ, Wen ZH, Huang QC. The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Front Pharmacol. 2018;9:356.PubMedPubMedCentral Zhou YY, Xia X, Peng WK, Wang QH, Peng JH, Li YL, Wu JX, Zhang JY, Zhao Y, Chen XM, Huang RY, Jakobsson PJ, Wen ZH, Huang QC. The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Front Pharmacol. 2018;9:356.PubMedPubMedCentral
15.
go back to reference Shen W, Guan YY, Wu RM, Liu LX, Li HD, Bao WL, Zhang YQ, Nandakumar KS, Shen XY. Protective effects of Wang-Bi tablet on bone destruction in collagen-induced arthritis by regulating osteoclast-osteoblast functions. J Ethnopharmacol. 2019;238:111861.PubMed Shen W, Guan YY, Wu RM, Liu LX, Li HD, Bao WL, Zhang YQ, Nandakumar KS, Shen XY. Protective effects of Wang-Bi tablet on bone destruction in collagen-induced arthritis by regulating osteoclast-osteoblast functions. J Ethnopharmacol. 2019;238:111861.PubMed
16.
go back to reference Ernst E, Chrubasik S. Phyto-anti-inflammatories: A Systematic Review of Randomized, Placebo-Controlled, Double-Blind Trials. Rheum Dis Clin N Am. 2000;26:13–27. Ernst E, Chrubasik S. Phyto-anti-inflammatories: A Systematic Review of Randomized, Placebo-Controlled, Double-Blind Trials. Rheum Dis Clin N Am. 2000;26:13–27.
17.
go back to reference Lu S, Wang Q, Li G, Sun S, Guo Y, Kuang H. The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms. J Ethnopharmacol. 2015;176:177–206.PubMed Lu S, Wang Q, Li G, Sun S, Guo Y, Kuang H. The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms. J Ethnopharmacol. 2015;176:177–206.PubMed
18.
go back to reference Moudgil KD, Berman BM. Traditional Chinese medicine: potential for clinical treatment of rheumatoid arthritis. Expert Rev Clin Immunol. 2014;10:819–22.PubMed Moudgil KD, Berman BM. Traditional Chinese medicine: potential for clinical treatment of rheumatoid arthritis. Expert Rev Clin Immunol. 2014;10:819–22.PubMed
19.
go back to reference Huang L, Dong Y, Wu J, Wang P, Zhou H, Li T, Liu L. Sinomenine-induced histamine release-like anaphylactoid reactions are blocked by tranilast via inhibiting NF-κB signaling. Pharmacol Res. 2017;125:150–60.PubMed Huang L, Dong Y, Wu J, Wang P, Zhou H, Li T, Liu L. Sinomenine-induced histamine release-like anaphylactoid reactions are blocked by tranilast via inhibiting NF-κB signaling. Pharmacol Res. 2017;125:150–60.PubMed
20.
go back to reference Xu M, Liu L, Qi C, Deng B, Cai X. Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Planta Med. 2008;74:1423–9.PubMed Xu M, Liu L, Qi C, Deng B, Cai X. Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Planta Med. 2008;74:1423–9.PubMed
21.
go back to reference Liu WW, Qian X, Ji W, Lu Y, Wei G, Wang Y. Effects and safety of Sinomenine in treatment of rheumatoid arthritis contrast to methotrexate: a systematic review and Meta-analysis. J Tradit Chin Med. 2016;36:564–77.PubMed Liu WW, Qian X, Ji W, Lu Y, Wei G, Wang Y. Effects and safety of Sinomenine in treatment of rheumatoid arthritis contrast to methotrexate: a systematic review and Meta-analysis. J Tradit Chin Med. 2016;36:564–77.PubMed
22.
go back to reference Feng ZT, Yang T, Hou XQ, Wu HY, Feng JT, Ou BJ, Cai SJ, Li J, Mei ZG. Sinomenine mitigates collagen-induced arthritis mice by inhibiting angiogenesis. Biomed Pharmacother. 2019;113:108759.PubMed Feng ZT, Yang T, Hou XQ, Wu HY, Feng JT, Ou BJ, Cai SJ, Li J, Mei ZG. Sinomenine mitigates collagen-induced arthritis mice by inhibiting angiogenesis. Biomed Pharmacother. 2019;113:108759.PubMed
23.
go back to reference Tong B, Yuan X, Dou Y, Wu X, Wang Y, Xia Y, Dai Y. Sinomenine induces the generation of intestinal Treg cells and attenuates arthritis via activation of aryl hydrocarbon receptor. Lab Investig. 2016;96:1076–86.PubMed Tong B, Yuan X, Dou Y, Wu X, Wang Y, Xia Y, Dai Y. Sinomenine induces the generation of intestinal Treg cells and attenuates arthritis via activation of aryl hydrocarbon receptor. Lab Investig. 2016;96:1076–86.PubMed
24.
go back to reference Liu W, Zhang Y, Zhu W, Ma C, Ruan J, Long H, Wang Y. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets. Front Immunol. 2018;9:2228.PubMedPubMedCentral Liu W, Zhang Y, Zhu W, Ma C, Ruan J, Long H, Wang Y. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets. Front Immunol. 2018;9:2228.PubMedPubMedCentral
25.
go back to reference Wei HH, Zhao XX, Chen L, Li SS, Song YL, Han TF, Ju DH, Hao BH. Research progress and prospects of sinomenine in the treatment of rheumatoid arthritis. Chin J Tradit Chin Med Pharm. 2013;28:3001–5. Wei HH, Zhao XX, Chen L, Li SS, Song YL, Han TF, Ju DH, Hao BH. Research progress and prospects of sinomenine in the treatment of rheumatoid arthritis. Chin J Tradit Chin Med Pharm. 2013;28:3001–5.
26.
go back to reference Wang Q, Li XK. Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol. 2011;11:373–6.PubMed Wang Q, Li XK. Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol. 2011;11:373–6.PubMed
27.
go back to reference Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.PubMedPubMedCentral Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.PubMedPubMedCentral
28.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;151:264–9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;151:264–9.
29.
go back to reference Mustafa RA, Santesso N, Brozek J, Akl EA, Walter SD, Norman G, Kulasegaram M, Christensen R, Guyatt GH, Falck-Ytter Y, Chang S, Murad MH, Vist GE, Lasserson T, Gartlehner G, Shukla V, Sun X, Whittington C, Post PN, Lang E, Thaler K, Kunnamo I, Alenius H, Meerpohl JJ, Alba AC, Nevis IF, Gentles S, Ethier MC, Carrasco-Labra A, Khatib R, Nesrallah G, Kroft J, Selk A, Brignardello-Petersen R, Schünemann HJ. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. J Clin Epidemiol. 2013;66:736–42.PubMed Mustafa RA, Santesso N, Brozek J, Akl EA, Walter SD, Norman G, Kulasegaram M, Christensen R, Guyatt GH, Falck-Ytter Y, Chang S, Murad MH, Vist GE, Lasserson T, Gartlehner G, Shukla V, Sun X, Whittington C, Post PN, Lang E, Thaler K, Kunnamo I, Alenius H, Meerpohl JJ, Alba AC, Nevis IF, Gentles S, Ethier MC, Carrasco-Labra A, Khatib R, Nesrallah G, Kroft J, Selk A, Brignardello-Petersen R, Schünemann HJ. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. J Clin Epidemiol. 2013;66:736–42.PubMed
30.
go back to reference Qi BJ, Liu CJ. Chinese herbal medicine for the treatment of rheumatoid arthritis with methotrexate as a control. J Mod Integr Med. 2010;19:2214–2216+2230. Qi BJ, Liu CJ. Chinese herbal medicine for the treatment of rheumatoid arthritis with methotrexate as a control. J Mod Integr Med. 2010;19:2214–2216+2230.
31.
go back to reference Zhang J, Wei W, Ji HY, Wang CM. Systematic evaluation of the efficacy and safety of Zhengqing Fengtongning combined with western medicine in the treatment of rheumatoid arthritis. Tianjin Med. 2012;40:1062–6. Zhang J, Wei W, Ji HY, Wang CM. Systematic evaluation of the efficacy and safety of Zhengqing Fengtongning combined with western medicine in the treatment of rheumatoid arthritis. Tianjin Med. 2012;40:1062–6.
32.
go back to reference Li RC, Li J. Zheng Qingfengtongning combined with methotrexate for the systematic evaluation of rheumatoid arthritis. Chin J Exp Tradit Med Form. 2012;18:1–4. Li RC, Li J. Zheng Qingfengtongning combined with methotrexate for the systematic evaluation of rheumatoid arthritis. Chin J Exp Tradit Med Form. 2012;18:1–4.
33.
go back to reference Wang BX, Li X, Gu J, Huang HY, Wang JG, Fan FY, Cai X. Systematic evaluation of the effectiveness and safety of Zhengqing Fengtongning in the treatment of rheumatoid arthritis. J Tradit Chin Med Univ Hunan. 2015;35:67–71. Wang BX, Li X, Gu J, Huang HY, Wang JG, Fan FY, Cai X. Systematic evaluation of the effectiveness and safety of Zhengqing Fengtongning in the treatment of rheumatoid arthritis. J Tradit Chin Med Univ Hunan. 2015;35:67–71.
34.
go back to reference Chen XM, Huang RY, Huang QC, Chu YL, Yan JY. Systemic Review and Meta-Analysis of the Clinical Efficacy and Adverse Effects of Zhengqing Fengtongning Combined with Methotrexate in Rheumatoid Arthritis. Evid Based Complement Alternat Med. 2015;2015:910376.PubMedPubMedCentral Chen XM, Huang RY, Huang QC, Chu YL, Yan JY. Systemic Review and Meta-Analysis of the Clinical Efficacy and Adverse Effects of Zhengqing Fengtongning Combined with Methotrexate in Rheumatoid Arthritis. Evid Based Complement Alternat Med. 2015;2015:910376.PubMedPubMedCentral
35.
go back to reference Li X, Wang BX, Li RY, Wang SZ, Gu J, Wei YX, Yu HH, Peng L, Song HP, Huang HY, Fan FY, Cai X. Systematic evaluation of randomized controlled trials of Zhengqing Fengtongning combined with chemical drugs for rheumatoid arthritis. Chin J Exp Tradit Med Form. 2016;22:205–10. Li X, Wang BX, Li RY, Wang SZ, Gu J, Wei YX, Yu HH, Peng L, Song HP, Huang HY, Fan FY, Cai X. Systematic evaluation of randomized controlled trials of Zhengqing Fengtongning combined with chemical drugs for rheumatoid arthritis. Chin J Exp Tradit Med Form. 2016;22:205–10.
36.
go back to reference Lunny C, Brennan SE, McDonald S, McKenzie JE. Evidence map of studies evaluating methods for conducting, interpreting and reporting overviews of systematic reviews of interventions: rationale and design. Syst Rev. 2016;5:4.PubMedPubMedCentral Lunny C, Brennan SE, McDonald S, McKenzie JE. Evidence map of studies evaluating methods for conducting, interpreting and reporting overviews of systematic reviews of interventions: rationale and design. Syst Rev. 2016;5:4.PubMedPubMedCentral
37.
go back to reference Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 3: systematic reviews and meta-analyses of randomized trials. Pain Physician. 2009;12:35–72.PubMed Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 3: systematic reviews and meta-analyses of randomized trials. Pain Physician. 2009;12:35–72.PubMed
38.
go back to reference Reza YN, Lohfeld L, Marin A, Hanneman R, Dobbins M. Informing the implementation of evidence-informed decision making interventions using a social network analysis perspective; a mixed-methods study. BMC Health Serv Res. 2017;17:122. Reza YN, Lohfeld L, Marin A, Hanneman R, Dobbins M. Informing the implementation of evidence-informed decision making interventions using a social network analysis perspective; a mixed-methods study. BMC Health Serv Res. 2017;17:122.
39.
go back to reference Guo X, Ji J, Feng Z, Hou X, Luo Y, Mei Z. A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis. Int Immunopharmacol. 2020;80:106201.PubMed Guo X, Ji J, Feng Z, Hou X, Luo Y, Mei Z. A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis. Int Immunopharmacol. 2020;80:106201.PubMed
40.
go back to reference Shen Q, Zhang X, Qi J, Shu G, Du Y, Ying X. Sinomenine hydrochloride loaded thermosensitive liposomes combined with microwave hyperthermia for the treatment of rheumatoid arthritis. Int J Pharm. 2020;576:119001.PubMed Shen Q, Zhang X, Qi J, Shu G, Du Y, Ying X. Sinomenine hydrochloride loaded thermosensitive liposomes combined with microwave hyperthermia for the treatment of rheumatoid arthritis. Int J Pharm. 2020;576:119001.PubMed
41.
go back to reference Waltman L, Traag VA. Use of the journal impact factor for assessing individual articles need not be wrong. arXiv preprint arXiv. 2017;1703:02334. Waltman L, Traag VA. Use of the journal impact factor for assessing individual articles need not be wrong. arXiv preprint arXiv. 2017;1703:02334.
42.
go back to reference Lucio BB, Lando T. A theoretical model of the relationship between the h-index and other simple citation indicators. Scientometric. 2017;111:1415–48. Lucio BB, Lando T. A theoretical model of the relationship between the h-index and other simple citation indicators. Scientometric. 2017;111:1415–48.
Metadata
Title
Methodological and reporting quality evaluation of meta-analyses on the Chinese herbal preparation Zheng Qing Feng Tong Ning for the treatment of rheumatoid arthritis
Authors
Mingge Liang
Lan Yan
Zhigang Mei
Yanan Luo
Xiaoqiang Hou
Zhitao Feng
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2020
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-020-02978-5

Other articles of this Issue 1/2020

BMC Complementary Medicine and Therapies 1/2020 Go to the issue